Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2021 Jan;57(1):106239.
doi: 10.1016/j.ijantimicag.2020.106239.

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret  1 , Van Thuan Hoang  2 , Jean-Christophe Lagier  3 , Didier Raoult  4
Affiliations
Clinical Trial

Effect of hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, an update with an intention-to-treat analysis and clinical outcomes

Philippe Gautret et al. Int J Antimicrob Agents. 2021 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare no competing interests.

References

    1. Saad MO. Letter to the editor about “Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial”. Int J Antimicrob Agents. 2021 - PMC - PubMed
    1. Liao X, Wang B, Kang Y. Novel coronavirus infection during the 2019-2020 epidemic: preparing intensive care units-the experience in Sichuan Province, China. Intensive Care Med. 2020;46:357–360. - PMC - PubMed
    1. European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 – first update. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidan... (Accessed 4 October, 2020).
    1. Lagier JC, Million M, Gautret P, Colson P, Cortaredona S, Giraud-Gatineau A. Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis. Travel Med Infect Dis. Jul-Aug 2020;36 - PMC - PubMed
    1. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents. Jul 2020;56(1) - PMC - PubMed

MeSH terms